Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
PET imaging of inflammation and fibrosis
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry, Translational PET Imaging. Uppsala University, Science for Life Laboratory, SciLifeLab.ORCID iD: 0000-0001-9636-0390
2024 (English)Doctoral thesis, comprehensive summary (Other academic)
Description
Abstract [en]

When the body faces an injury, the immune system triggers inflammation to initiate tissue repair. However, dysregulation of this process can lead to chronic inflammation, driving persistent scar formation and resulting in fibrosis. Fibrosis, characterised by pathological scar tissue accumulation, impairs organ function which could ultimately lead to death. Despite its clinical significance, treatment options remain limited. Positron Emission Tomography (PET) imaging, a highly sensitive and quantitative technique, offers significant potential for the non-invasive assessment of inflammatory and fibrotic processes.

Papers I and II investigate the Affibody molecule Z09591, which targets platelet-derived growth factor receptor β (PDGFR β), as a PET tracer for assessing liver fibrogenesis in a murine model of toxin-induced fibrosis (the CCl4 model). PDGFRβ, expressed on fibrogenic cells such as activated hepatic stellate cells, is absent in quiescent cells. Two radiolabeling techniques were compared: the TCO-TZ conjugation method ([18F]TZ-Z09591, Paper I) and the Al18F-RESCA method ([18F]AlF-RESCA-Z09591, Paper II). Both tracers demonstrated specific uptake in fibrotic regions with low liver background, highlighting their potential for non-invasive assessment of fibrogenic activity. These findings have supported the initiation of a first-in-human clinical trial evaluating a Z09591-based PET tracer.

Papers III and IV focus on two PET tracers, [¹¹C]NES and [68Ga]Ga-FAPI-46, targeting neutrophil elastase (NE) and fibroblast activation protein (FAP), respectively, in pulmonary fibrosis. NE is a protease released by activated neutrophils, while FAP is expressed on activated fibroblasts. Sequential PET scans were performed in patients with long COVID-19 (Paper III) and interstitial lung disease (Paper IV), with [¹¹C]NES assessing neutrophil-mediated inflammation and [68Ga]Ga-FAPI-46 imaging tissue remodeling activity. Tracer uptake correlated with lung abnormalities seen on computed tomography scans, underscoring their potential in imaging inflammation and tissue remodeling activity processes.

Given the complex pathogenesis of fibrosis and the lack of curative treatments, PET tracers that enable earlier diagnosis and disease monitoring may improve patient management and support the development of anti-fibrotic therapies.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2024. , p. 83
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 366
Keywords [en]
Fibrosis, Inflammation, PET imaging, Molecular imaging, Translational medicine, Radioligand, Fibroblast activated protein (FAP), Neutrophil elastase (NE), Platelet-derived growth factor receptor beta (PDGFRβ), Liver fibrosis, Pulmonary fibrosis
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-543028ISBN: 978-91-513-2313-8 (print)OAI: oai:DiVA.org:uu-543028DiVA, id: diva2:1915255
Public defence
2025-01-16, H:son Holmdahlsalen, Hus 100, Akademiska sjukhuset, Uppsala, 10:00 (English)
Opponent
Supervisors
Available from: 2024-12-20 Created: 2024-11-22 Last updated: 2024-12-20
List of papers
1. Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β
Open this publication in new window or tab >>Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β
Show others...
2023 (English)In: EJNMMI Radiopharmacy and Chemistry, E-ISSN 2365-421X, Vol. 8, article id 23Article in journal (Refereed) Published
Abstract [en]

Background: Platelet-derived growth factor receptor beta (PDGFR beta) is a receptor overexpressed on activated hepatic stellate cells (aHSCs). Positron emission tomography (PET) imaging of PDGFR beta could potentially allow the quantification of fibrogenesis in fibrotic livers. This study aims to evaluate a fluorine-18 radiolabeled Affibody molecule ([F-18]TZ-Z09591) as a PET tracer for imaging liver fibrogenesis.

Results: In vitro specificity studies demonstrated that the trans-Cyclooctenes (TCO) conjugated Z09591 Affibody molecule had a picomolar affinity for human PDGFR beta. Biodistribution performed on healthy rats showed rapid clearance of [F-18]TZ-Z09591 through the kidneys and low liver background uptake. Autoradiography (ARG) studies on fibrotic livers from mice or humans correlated with histopathology results. Ex vivo biodistribution and ARG revealed that [F-18]TZ-Z09591 binding in the liver was increased in fibrotic livers (p = 0.02) and corresponded to binding in fibrotic scars.

Conclusions: Our study highlights [F-18]TZ-Z09591 as a specific tracer for fibrogenic cells in the fibrotic liver, thus offering the potential to assess fibrogenesis clearly.

Place, publisher, year, edition, pages
Springer NatureSpringer Nature, 2023
Keywords
PET imaging, Platelet derived growth factor receptor, Hepatic stellate cells, Fibrogenesis, Liver fibrosis
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
urn:nbn:se:uu:diva-514754 (URN)10.1186/s41181-023-00210-6 (DOI)001075551000001 ()37733133 (PubMedID)
Funder
Magnus Bergvall FoundationEuropean Foundation for the Study of DiabetesSwedish Research Council, 2020-02312Swedish Child Diabetes Foundation
Available from: 2023-10-26 Created: 2023-10-26 Last updated: 2024-12-03Bibliographically approved
2. Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated Affibody molecule
Open this publication in new window or tab >>Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated Affibody molecule
Show others...
2024 (English)In: iScience, E-ISSN 2589-0042, Vol. 27, no 5, article id 109688Article in journal (Refereed) Published
Abstract [en]

Non-invasive assessment of fibrogenic activity, rather than fibrotic scars, could significantly improve the management of fibrotic diseases and the development of anti-fibrotic drugs. This study explores the potential of an Affibody molecule (Z09591) labeled with the Al(18)F-restrained complexing agent (RESCA) method as a tracer for the non-invasive detection of fibrogenic cells. Z09591 was functionalized with the RESCA chelator for direct labeling with [18F]AlF. 18 F]AlF. In vivo positron emission tomography/magnetic resonance imaging scans on U-87 tumor-bearing mice exhibited high selectivity of the resulting radiotracer, [18F]AlF-RESCA-Z09591, 18 F]AlF-RESCA-Z09591, for platelet-derived growth factor receptor b (PDGFRb), b ), with minimal non-specific background uptake. Evaluation in a mouse model with carbon tetrachloride-induced fibrotic liver followed by a disease regression phase, revealed the radiotracer's high affinity and specificity for fibrogenic cells in fibrotic livers (standardized uptake value [SUV] 0.43 +/- 0.05), with uptake decreasing during recovery (SUV 0.29 +/- 0.03) (p p < 0.0001). [18F]AlF-RESCA-Z09591 18 F]AlF-RESCA-Z09591 accurately detects PDGFRb, b, offering noninvasive assessment of fibrogenic cells and promising applications in precise liver fibrogenesis diagnosis, potentially contributing significantly to anti-fibrotic drug development.

Place, publisher, year, edition, pages
Elsevier, 2024
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
urn:nbn:se:uu:diva-537082 (URN)10.1016/j.isci.2024.109688 (DOI)001288013000001 ()38660405 (PubMedID)
Funder
Swedish Research Council, 2020-02312Swedish Child Diabetes FoundationDiabetesfonden
Available from: 2024-08-29 Created: 2024-08-29 Last updated: 2024-11-22Bibliographically approved
3. Exploring impacts of long-COVID-19 on the lungs: A triad of PET scans for perfusion, inflammation and tissue remodeling
Open this publication in new window or tab >>Exploring impacts of long-COVID-19 on the lungs: A triad of PET scans for perfusion, inflammation and tissue remodeling
Show others...
(English)Manuscript (preprint) (Other academic)
Keywords
PET imaging, chest imaging, COVID-19, FAP, neutrophil elastase, fibrosis, inflammation
National Category
Pharmaceutical Sciences
Identifiers
urn:nbn:se:uu:diva-543065 (URN)
Available from: 2024-11-18 Created: 2024-11-18 Last updated: 2024-11-22
4. Investigating inflammation and tissue remodeling in ILD with [11C]NES and [68Ga]Ga-FAPI-46 PET imaging
Open this publication in new window or tab >>Investigating inflammation and tissue remodeling in ILD with [11C]NES and [68Ga]Ga-FAPI-46 PET imaging
Show others...
(English)Manuscript (preprint) (Other academic)
Keywords
Lung fibrosis, inflammation, neutrophil, FAP, PET
National Category
Pharmaceutical Sciences
Identifiers
urn:nbn:se:uu:diva-543073 (URN)
Available from: 2024-11-18 Created: 2024-11-18 Last updated: 2024-11-22

Open Access in DiVA

UUThesis_O-Wegrzyniak-2024(2018 kB)46 downloads
File information
File name FULLTEXT01.pdfFile size 2018 kBChecksum SHA-512
11bd1c13344da1437e8a9fca01d7678ae794def43307a972bd6ac6d22c5b95e8811c1ba8ee614b3b76a3c4a94a863174f294f56ed2fe302fbaa81af915d44175
Type fulltextMimetype application/pdf

Authority records

Wegrzyniak, Olivia

Search in DiVA

By author/editor
Wegrzyniak, Olivia
By organisation
Translational PET ImagingScience for Life Laboratory, SciLifeLab
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 46 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 253 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf